Genitourinary Cancer section

Genitourinary Cancer News & Features

Outcomes in Bladder Cancer Tend to Be Poorer With Higher Body Mass Index

Outcomes in Bladder Cancer Tend to Be Poorer With Higher Body Mass Index

An increased body mass index (BMI) may negatively affect disease progression in patients with T1G3 non-muscle-invasive bladder cancer, according to study data.

Metformin Use May Improve Survival Outcomes in Bladder Cancer

Metformin Use May Improve Survival Outcomes in Bladder Cancer

A review and meta-analysis evaluated the association between metformin use and bladder cancer incidence and various prognostic measures, such as PFS and OS.

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.

5-ARI Use Before, After Diagnosis Significantly Reduced Bladder Cancer-Specific Death

5-ARI Use Before, After Diagnosis Significantly Reduced Bladder Cancer-Specific Death 

Study results support the role of androgens and benefits of 5-alpha-reductase inhibition in the progression of bladder cancer.

Recruitment for 2 Trials of Investigational ADC for Urothelial Cancer Underway

Recruitment for 2 Trials of Investigational ADC for Urothelial Cancer Underway

Enfortumab vedotin was granted Breakthrough Therapy Designation by the US Food and Drug Administration (FDA), based on interim results from a Phase 1 study.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs